gadolinium dtpa has been researched along with Dysesthesia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babikian, VL; Bhatia, R; Pansing, SS; Venna, N | 1 |
| Blumenfield, DM; Blumetti, RF; Goldstein, HA; Holyoak, WL; Hugo, FP; Kashanian, FK | 1 |
1 trial(s) available for gadolinium dtpa and Dysesthesia
| Article | Year |
|---|---|
Safety assessment of gadopentetate dimeglumine in U.S. clinical trials.
Topics: Bilirubin; Clinical Trials as Topic; Contrast Media; Drug Combinations; Electrocardiography; Electroencephalography; Gadolinium; Gadolinium DTPA; Headache; Humans; Iron; Magnetic Resonance Imaging; Meglumine; Nausea; Organometallic Compounds; Paresthesia; Pentetic Acid; Research Design; Sorbitol; United States | 1990 |
1 other study(ies) available for gadolinium dtpa and Dysesthesia
| Article | Year |
|---|---|
Pain, paresthesias, and weakness of the extremities in a young man.
Topics: Adult; Contrast Media; Diagnosis, Differential; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Muscle Weakness; Neurilemmoma; Organometallic Compounds; Pain; Paresthesia; Pentetic Acid; Spinal Cord Compression; Spinal Cord Neoplasms; Tomography, X-Ray Computed | 1997 |